Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$0.36 - $0.57 $360 - $570
-1,000 Reduced 5.26%
18,015 $9,000
Q4 2021

Feb 03, 2022

SELL
$0.46 - $0.94 $207 - $423
-450 Reduced 2.31%
19,015 $9,000
Q3 2021

Nov 02, 2021

BUY
$0.86 - $1.21 $2,463 - $3,466
2,865 Added 17.26%
19,465 $17,000
Q2 2021

Aug 10, 2021

SELL
$1.04 - $1.69 $1,612 - $2,619
-1,550 Reduced 8.54%
16,600 $19,000
Q1 2021

May 07, 2021

BUY
$1.32 - $3.79 $4,290 - $12,317
3,250 Added 21.81%
18,150 $29,000
Q4 2020

Feb 04, 2021

BUY
$1.06 - $1.51 $3,392 - $4,832
3,200 Added 27.35%
14,900 $18,000
Q3 2020

Oct 29, 2020

SELL
$1.15 - $2.1 $1,035 - $1,890
-900 Reduced 7.14%
11,700 $15,000
Q2 2020

Jul 27, 2020

BUY
$0.48 - $1.67 $432 - $1,503
900 Added 7.69%
12,600 $16,000
Q4 2019

Feb 04, 2020

BUY
$0.96 - $2.94 $11,232 - $34,398
11,700 New
11,700 $13,000

About T2 Biosystems, Inc.


  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $5.99M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.